GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.

GSK (GSK) on Wednesday announced a settlement resolving a bundle of 80,000 product liability cases in the US that alleged its over-the-counter heartburn medication, Zantac, increased the risk of ...

MG has been named the most unreliable car manufacturer following a survey of nearly 30,000 owners. What Car? quizzed 29,967 owners of used cars up to five-years-old about how often their vehicles had ...

A new nationwide drive-away offer for the base MG 4 electric hatch sees pricing cut by between $8000 and over $10,000 depending on where you live.

MG has launched the Windsor in India as its third EV, joining the likes of Comet and ZS EV. The crossover-styled electric hatch is priced from Rs 13.50 lakh to Rs 15.50 lakh. MG is also offering a ...

In an innovative move to make electric vehicles (EVs) more accessible, MG has launched the Windsor, its third EV, with a unique Battery-as-a-Service (BaaS) program, starting at a price of Rs 9.99 ...

But MG has found a way to bring down that initial cost of ownership with their newly launched Windsor EV and its Battery-as-a-Service (BaaS) Rental Program. In this story, we take a deep dive into ...

Minimalism seem to be the theme for the Windsor EV as it gets a rather clean looking exterior and interior MG Motor India has introduced its latest model, the Windsor EV, at Rs 9.99 lakh (ex ...

A historic one too, because – oi, oi – this is nothing less than the rebirth of the MG sports car. It’s a long time since we’ve seen a new MG sports car – the MG F was really the last ...

A Chicago jury failed to reach a verdict Sept. 18 over claims that heartburn drug Zantac causes cancer, Reuters exclusively reported. The case, brought by Illinois resident Ronald Kimbrow ...

By Brendan Pierson (Reuters) -The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, as jurors in Chicago were unable to agree ...

A Chicago jury failed to reach a verdict in the latest Zantac cancer trial involving Boehringer Ingelheim. Plaintiff Ronald Kimbrow claims the heartburn drug caused his prostate cancer. This marks the ...